| Biologic Therapy |
1 |
1 |
| Biliary Disease |
0 |
0.68 |
| Diarrhea |
0 |
0.58 |
| Hepatitis |
0 |
0.55 |
| Hepatitis A |
0 |
0.52 |
| Toxicology |
0 |
0.47 |
| Inflammatory Bowel Disease |
0 |
0.45 |
| Dentistry and Oral Health |
0 |
0.42 |
| Cancer |
0 |
0.4 |
| Colitis |
0 |
0.4 |
| Autoimmune Hepatitis |
0 |
0.39 |
| Colorectal Cancer |
0 |
0.33 |
| Abdominal Pain |
0 |
0.25 |
| Pain Management |
0 |
0.25 |
| Aminotransferase |
0 |
0.22 |
| Anti-CTLA4 Antibodies |
0 |
0.22 |
| Abdomen |
0 |
0.2 |
| Immunotherapy |
0 |
0.2 |
| Liver |
0 |
0.2 |
| Abdominal Abscess |
0 |
0.18 |
| Abdominal Ultrasound |
0 |
0.18 |
| Corticosteroid Taper |
0 |
0.17 |
| CT Scan |
0 |
0.17 |
| T-Lymphocyte |
0 |
0.17 |
| Abdominal Infection |
0 |
0.16 |
| Corticosteroids |
0 |
0.16 |
| Liver Biopsy |
0 |
0.16 |
| Pancreatitis |
0 |
0.13 |
| Adverse Effects |
0 |
0.12 |
| Biliary Obstruction |
0 |
0.12 |
| Cholangitis |
0 |
0.12 |
| Clinical Guidelines |
0 |
0.12 |
| Lymphocytes |
0 |
0.12 |
| Pain |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Steroids |
0 |
0.12 |
| Tumor |
0 |
0.12 |
| A-Scan Biometry |
0 |
0.09 |
| Acalculous Cholecystitis |
0 |
0.09 |
| Care and Maintenance of Vision |
0 |
0.09 |
| Cataract |
0 |
0.09 |
| Sepsis |
0 |
0.09 |
| Abscess |
0 |
0.08 |
| California |
0 |
0.08 |
| Cholecystitis |
0 |
0.08 |
| Endoscopy |
0 |
0.08 |
| Histology |
0 |
0.08 |
| Melanoma |
0 |
0.08 |
| Ultrasonography |
0 |
0.08 |
| Fluid Resuscitation |
0 |
0.06 |
| Hodgkin Lymphoma |
0 |
0.06 |
| Acute Pancreatitis |
0 |
0.04 |
| Analgesia |
0 |
0.04 |
| Aphthous Ulcer |
0 |
0.04 |
| Biliary Tract |
0 |
0.04 |
| Biopsy |
0 |
0.04 |
| Chemotherapy |
0 |
0.04 |
| Cytomegalovirus |
0 |
0.04 |
| Drug Development |
0 |
0.04 |
| Epstein-Barr Virus |
0 |
0.04 |
| ERCP |
0 |
0.04 |
| Esophagitis |
0 |
0.04 |
| Factor II |
0 |
0.04 |
| Fever |
0 |
0.04 |
| Flexible Sigmoidoscopy |
0 |
0.04 |
| Gallbladder |
0 |
0.04 |
| Gastritis |
0 |
0.04 |
| Haematochezia |
0 |
0.04 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Immunomodulator |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Jaundice |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Lymphoma |
0 |
0.04 |
| Meta-Analysis |
0 |
0.04 |
| Monoclonal Antibody |
0 |
0.04 |
| Multidisciplinary Team |
0 |
0.04 |
| Nutritional Support |
0 |
0.04 |
| Oral Cavity |
0 |
0.04 |
| Pancreas |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Resuscitation |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Serology |
0 |
0.04 |
| Toxic Megacolon |
0 |
0.04 |
| Wound Management |
0 |
0.04 |